Clinical Trial Update: Registry of the Combination of Antiplatelet Agents and Anticoagulant in Atrial Fibrillation Patients With a CHA2DS2VASc Score >1 Undergoing Percutaneous Coronary Interventions

View source ↗

Summary

Clinical trial registry update on combining antiplatelet agents and anticoagulants in atrial fibrillation patients undergoing percutaneous coronary intervention…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Percutaneous Coronary Intervention | Status: UNKNOWN